UCSF COVID-19 Vaccine Information Hub

Updated January 22, 2021

UCSF is taking a phased, equity-driven approach to vaccine distribution for our workforce, students and patients. This page provides the latest information about our distribution plans.

Please remember that vaccines are just one tool to help protect against COVID-19. Until the pandemic has ended, everyone­ – including those who have been vaccinated – should continue to:

  • Follow public health orders
  • Wear masks
  • Physically distance
  • Practice hand hygiene
  • Avoid unnecessary travel and gatherings
  • Complete daily health screening (for UCSF employees)
  • Wear appropriate eye protection (for all staff in clinical areas)


Latest Updates

Vaccination Phases

Vaccinating Now

  • Phase 1A: Health care workers and other on-site employees and learners whose responsibilities involve high-risk exposure 
  • UCSF patients and employees age 75 and over (by appointment via MyChart only)

Learn more

Coming Up

  • UCSF patients & employees age 65 and over
  • Additional UCSF employees working on site
  • Other Phase 1B, including essential workers not yet vaccinated, per CDPH Guidelines

Later Phases

Please Note: Patients and employees age 65 and above are eligible to receive the vaccine, according to state guidelines. However, because vaccine doses remain limited, UCSF has partitioned eligible patients and employees into subgroups and is prioritizing the vaccine for those groups at highest risk. We will make the vaccine available to all eligible patients and employees as vaccine supplies increase.


For Employees, Students, Contractors

Information about vaccine availability, scheduling and how submit vaccine questions.

For Managers

Guidance for managers about vaccination policy, answering employee questions, HR Umbrella tutorials, and FAQs. (MyAccess required)

For Patients

Information about vaccines for UCSF Health patients, including when it will be available and how to get one.


Vaccine Education and Resources

What We Currently Know:
  • Pfizer and Moderna announced in mid-November that their COVID-19 vaccines were 95% and 94.5% effective, respectively, in human trials.

  • Pfizer’s vaccine requires two doses 21 days apart. Moderna’s requires two doses 28 days apart. The vaccines reach peak efficacy a week after the second dose is administered.

  • Both the Pfizer and Moderna vaccines received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration in December 2020.
  • Both the Pfizer and Moderna vaccines are mRNA vaccines, a new vaccine technology based on well-established science.
  • mRNA vaccines must be stored at low or ultralow temperatures (-70 °C for Pfizer’s vaccine, -20 °C for Moderna’s).

  • Most vaccine trial participants did not experience side effects, though a small fraction reported mild to severe side effects that eventually went away.

  • Many more COVID-19 vaccines are being developed and tested, and vaccine trials in children under 12 are underway.
What We Don't Yet Know:
  • How long immunity against COVID-19 lasts after a person has been vaccinated.

  • Whether those who received a COVID-19 vaccine could still transmit disease to others without getting sick themselves.

  • Whether vaccinations for the general public will be provided for free and if any associated charges will be covered by a person’s health insurance.
  • There’s currently no data on the safety and efficacy of COVID-19 vaccines in pregnant women, children or individuals who are immunocompromised.

Frequently Asked Questions

If you are a UCSF patient, find more FAQs on the Patient Hub.

More vaccine questions? Email [email protected]